Table 5.
Subject/patient | SUVmean | SUVmax | CV | Percent of bone marrow with SUV greater than 8 |
---|---|---|---|---|
Normal controls (n = 10) | 1.87 | 9.9 | 0.89 | 1 |
CR pre-treatment (n = 1) | 2.02 | 14.9 | 0.83 | 1 |
RD pre-treatment (n = 1) | 3.17 | 28.4 | 1.12 | 11 |
Subject/patient | SUVmean | SUVmax | CV | Percent of bone marrow with SUV greater than 8 |
---|---|---|---|---|
Normal controls (n = 10) | 1.87 | 9.9 | 0.89 | 1 |
CR pre-treatment (n = 1) | 2.02 | 14.9 | 0.83 | 1 |
RD pre-treatment (n = 1) | 3.17 | 28.4 | 1.12 | 11 |